Dataset Information


A redox-mediated Kemp eliminase.

ABSTRACT: The acid/base-catalysed Kemp elimination of 5-nitro-benzisoxazole forming 2-cyano-4-nitrophenol has long served as a design platform of enzymes with non-natural reactions, providing new mechanistic insights in protein science. Here we describe an alternative concept based on redox catalysis by P450-BM3, leading to the same Kemp product via a fundamentally different mechanism. QM/MM computations show that it involves coordination of the substrate's N-atom to haem-Fe(II) with electron transfer and concomitant N-O heterolysis liberating an intermediate having a nitrogen radical moiety Fe(III)-N· and a phenoxyl anion. Product formation occurs by bond rotation and H-transfer. Two rationally chosen point mutations cause a notable increase in activity. The results shed light on the prevailing mechanistic uncertainties in human P450-catalysed metabolism of the immunomodulatory drug leflunomide, which likewise undergoes redox-mediated Kemp elimination by P450-BM3. Other isoxazole-based pharmaceuticals are probably also metabolized by a redox mechanism. Our work provides a basis for designing future artificial enzymes.


PROVIDER: S-EPMC5379065 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5446047 | BioStudies
2010-01-01 | S-EPMC2947920 | BioStudies
2011-01-01 | S-EPMC3889864 | BioStudies
2012-01-01 | S-EPMC3387081 | BioStudies
2011-01-01 | S-EPMC3086991 | BioStudies
2013-01-01 | S-EPMC3818519 | BioStudies
2020-01-01 | S-EPMC7307895 | BioStudies
2010-01-01 | S-EPMC2973866 | BioStudies
2013-01-01 | S-EPMC3720782 | BioStudies
2019-01-01 | S-EPMC6367340 | BioStudies